Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed antibiotic prescribing for uncomplicated pediatric respiratory tract infections
2011-005741-13Phase 4Active
- Sponsor
- Cochrane Iberoamérica
- Start
- Dec 2011
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin and phenoxymethylpenicillin in acute respiratory illness (ARI), acute otitis media (AOM), acute rhinosinusitis (ARS) and 2 more (3 arms), sponsored by Cochrane Iberoamérica. Primary endpoint: Duration and severity of symptoms. Started Dec 2011; status: active.
02
Drugs
amoxicillinphenoxymethylpenicillin
03
Conditions
acute respiratory illness (ARI)acute otitis media (AOM)acute rhinosinusitis (ARS)tonsillopharyngitisacute bronchitis
Beyond the preview
Go deeper on 2011-005741-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005741-13.